BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18607065)

  • 41. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
    Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
    Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.
    Tischkowitz MD; Morgan NV; Grimwade D; Eddy C; Ball S; Vorechovsky I; Langabeer S; Stöger R; Hodgson SV; Mathew CG
    Leukemia; 2004 Mar; 18(3):420-5. PubMed ID: 14749703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe telomere shortening in Fanconi anemia complementation group L.
    Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
    Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic correction of Fanconi anemia group C knockout mice.
    Gush KA; Fu KL; Grompe M; Walsh CE
    Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helq acts in parallel to Fancc to suppress replication-associated genome instability.
    Luebben SW; Kawabata T; Akre MK; Lee WL; Johnson CS; O'Sullivan MG; Shima N
    Nucleic Acids Res; 2013 Dec; 41(22):10283-97. PubMed ID: 24005041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of p300 gene promoter methylation in acute leukemia.
    Chim CS; Wong AS; Kwong YL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):164-7. PubMed ID: 15066326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature.
    Thompson AS; Saba N; McReynolds LJ; Munir S; Ahmed P; Sajjad S; Jones K; Yeager M; Donovan FX; Chandrasekharappa SC; Alter BP; Savage SA; Rehman S
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1693. PubMed ID: 33960719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drosophila homologs of FANCD2 and FANCL function in DNA repair.
    Marek LR; Bale AE
    DNA Repair (Amst); 2006 Nov; 5(11):1317-26. PubMed ID: 16860002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
    Schafer E; Irizarry R; Negi S; McIntyre E; Small D; Figueroa ME; Melnick A; Brown P
    Blood; 2010 Jun; 115(23):4798-809. PubMed ID: 20215641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukemia and chromosomal instability in aged Fancc-/- mice.
    Cerabona D; Sun Z; Nalepa G
    Exp Hematol; 2016 May; 44(5):352-7. PubMed ID: 26860989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
    Qiao F; Moss A; Kupfer GM
    J Biol Chem; 2001 Jun; 276(26):23391-6. PubMed ID: 11297559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.
    García-de Teresa B; Frias S; Molina B; Villarreal MT; Rodriguez A; Carnevale A; López-Hernández G; Vollbrechtshausen L; Olaya-Vargas A; Torres L
    Mol Genet Genomic Med; 2019 Jun; 7(6):e710. PubMed ID: 31044565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype.
    Estécio MR; Maddipoti S; Bueso-Ramos C; DiNardo CD; Yang H; Wei Y; Kondo K; Fang Z; Stevenson W; Chang KS; Pierce SA; Bohannan Z; Borthakur G; Kantarjian H; Garcia-Manero G
    Br J Haematol; 2015 May; 169(3):344-51. PubMed ID: 25612675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.